Cangene

Fully integrated developer and manufacturer of immune therapeutics our first drug, winrho® sdf, has been commercially.

Launch date

1984

Employees

Baltimore Maryland (HQ)

Date	Investors	Amount	Round
-	Signet Healthcare Partners	N/A	-
Dec 2013	Emergent BioSolutions	N/A	Acquisition
Total Funding		-

ACQUISITION by Cangene Jul 2009

Recent News about Cangene